Appetite News and Research

RSS

Phase 3 EMT2 trial demonstrates survival benefit for high-dose EPA

Patients assigned to receive high-dose eicosapentaenoic acid (EPA), an omega-3 fatty acid, before and after surgery for colorectal cancer liver metastases had longer overall survival than those assigned to receive placebo, according to results of the phase 3 EMT2 trial presented at the ESMO Congress 2026.

26 Oct 2026

Can happy feelings trigger eating too? Researchers explored both sides of emotional eating

Among 3,834 members of weight-management programs, greater recent weight loss was associated with less emotional eating, fewer food cravings, and better mood. Participants identified distraction, meal planning, healthier food swaps, and group support as helpful strategies, but the observational study could not establish whether these approaches caused weight loss.

25 Oct 2026

Semaglutide and teduglutide reduce immune-driven gut injury in mice

Researchers found that gut-derived GLP-1 and GLP-2 signaling helped protect mice against T cell-induced intestinal injury, with GLP-1R primarily regulating inflammation and GLP-2R supporting intestinal repair. Semaglutide and teduglutide, administered separately or together, reduced acute intestinal damage in mice lacking intestinal proglucagon, suggesting potential avenues for investigating treatments for immune-mediated gut injury.

21 Oct 2026

Anxiety and depression linked to higher levels of pregnancy "brain fog"

Symptoms of anxiety and depression are associated with higher levels of "pregnancy brain," which is also known as "baby brain," "brain fog" or "momnesia," according to a new study by Penn State researchers.

20 Oct 2026

Could ultraprocessed foods affect your brain before you notice?

Ultraprocessed food intake correlates with increased body fat and vascular brain injury in middle-aged adults, though cognitive performance remains unaffected.

19 Oct 2026

Could this flowering plant help people lose body fat?

Lythrum salicaria extract supplementation led to body fat reduction in a clinical trial, suggesting a promising plant-based approach to weight management.

19 Oct 2026

Scientists expand global climate scenarios to include public health

About a decade ago, a group of climate scientists described five scenarios for the future. Called the Shared Socioeconomic Pathways (SSPs), these scenarios suggest how socioeconomic development could evolve in worlds with differing challenges to climate adaptation and mitigation.

15 Oct 2026

Losing weight is one thing. Keeping your muscle is another, experts say

The International Society of Sports Nutrition (ISSN) position stand concludes that sustained calorie restriction drives weight loss, while adequate protein intake and resistance training help preserve lean mass. Reviewing intermittent fasting, ketogenic diets, and other dietary approaches, the authors emphasize individualized nutrition plans, body composition, and sustainable weight management rather than rapid weight loss alone.

14 Oct 2026

New study tracks how eating behaviors vary with age, sex and body weight

Eating behavior varies with age and body weight. A University of Oulu study found that emotional and uncontrolled eating are more pronounced in younger adults, while cognitive restraint is more common among older people. Sex and body weight also influence which eating behaviors are typical.

12 Oct 2026

Severe long Covid associated with distinct oral and lung microbiomes

A study of more than 700 people has shown that those with long Covid have distinct differences in the mix of bacteria that live in their mouths and lungs, according to a study published today (Monday) in the European Respiratory Journal.

11 Oct 2026

Body fat distribution may influence hunger hormones more than daily diet

Body fat distribution may reveal more about hunger hormones than recent diet.

9 Oct 2026

Overweight dementia patients likely to live longer than normal weight peers

People who are overweight or obese when they are diagnosed with dementia are likely to live longer than those in a normal weight range, according to a new study by Columbia University Mailman School of Public Health and NYU School of Global Public Health.

6 Oct 2026

Health evidence favors permanent standard time, Canadian analysis finds

Several Canadian jurisdictions are moving toward ending the twice-yearly clock change, but a new analysis published in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.261089 argues that eliminating the clock change is only half the decision: governments must also decide whether to adopt permanent standard time or permanent daylight saving time.

5 Oct 2026

Taste and familiarity shape student attitudes toward climate-friendly meals

Students in a new study were neither clearly positive nor negative about more climate-friendly school meals.

5 Oct 2026

Owning a smartphone at 12 linked to eating disorder symptoms

Early smartphone use is linked to a rise in eating disorder symptoms among adolescents, indicating potential mental health implications that require attention.

30 Sep 2026

Petrelintide produces double-digit weight loss with fewer side effects

New research to be presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) and published in The Lancet Diabetes & Endocrinology shows that weekly injections with the new amylin-based obesity drug petrelintide can enable those treated to lose more than 10% of their body weight – generally lower than existing incretin-based (GLP-1 RA) drugs, but also with far fewer side effects.

29 Sep 2026

Study identifies three cell clusters driving pancreatic cancer-induced cachexia

Research published today in Cell identifies three small subclusters of cells driving pancreatic cancer-induced cachexia, a muscle-wasting and fat-loss condition that makes patients less tolerant of cancer treatment.

29 Sep 2026

University of Liverpool study tracks long-term impact of non-nutritive sweetened soft drinks

Researchers at the University of Liverpool have conducted the longest and most comprehensive randomized controlled trial on non-nutritive sweetened (NNS) soft drinks.

29 Sep 2026

Experts call for eating-disorder screening before GLP-1 treatment

An international multidisciplinary panel developed consensus-based recommendations for GLP-1 receptor agonist use in people with eating disorders, calling for screening, individualized monitoring, patient education, and further research into safety and potential therapeutic effects. The experts cautioned that current evidence remains limited and inconsistent, particularly outside binge eating disorder, and identified major gaps in understanding the risk of new or recurrent eating disorders during treatment.

16 Sep 2026

Subcutaneous tarlatamab exhibits low toxicity rates in phase 1b trial

Subcutaneous administration of tarlatamab was well tolerated and demonstrated preliminary antitumor activity in patients with previously treated extensive-stage small cell lung cancer (ES-SCLC), according to findings from the phase 1b DeLLphi-308 study presented at the International Association for the Study of Lung Cancer (IASLC) 2026 World Conference on Lung Cancer (WCLC).

12 Sep 2026